Manav Rakshak Hospitals Profile
Key Indicators
- Authorised Capital ₹ 15.00 Cr
as on 24-10-2024
- Paid Up Capital ₹ 12.50 Cr
as on 24-10-2024
- Company Age 18 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 53.23 Cr
as on 24-10-2024
- Satisfied Charges ₹ 30.69 Cr
as on 24-10-2024
- Revenue 41.06%
(FY 2023)
- Profit 3.35%
(FY 2023)
- Ebitda 135.74%
(FY 2023)
- Net Worth 71.79%
(FY 2023)
- Total Assets 281.90%
(FY 2023)
About Manav Rakshak Hospitals
The Corporate was formerly known as Manav Rakshak Cancer Hospitals Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 15.00 Cr and a paid-up capital of Rs 12.50 Cr.
The company currently has active open charges totaling ₹53.23 Cr. The company has closed loans amounting to ₹30.69 Cr, as per Ministry of Corporate Affairs (MCA) records.
Manav Rakshak and Gitanjali Gupta serve as directors at the Company.
- CIN/LLPIN
U85110DL2006PTC154146
- Company No.
154146
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Sep 2006
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Manav Rakshak Hospitals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manav Rakshak  | Director | 20-Sep-2006 | Current |
| Gitanjali Gupta | Director | 20-Sep-2006 | Current |
Financial Performance of Manav Rakshak Hospitals.
Manav Rakshak Hospitals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 41.06% increase. The company also saw a slight improvement in profitability, with a 3.35% increase in profit. The company's net worth Soared by an impressive increase of 71.79%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Manav Rakshak Hospitals?
In 2023, Manav Rakshak Hospitals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 18 Sep 2024 | ₹40.29 Cr | Open |
Others Creation Date: 19 May 2023 | ₹10.00 Cr | Open |
Others Creation Date: 25 Feb 2022 | ₹3.09 M | Open |
How Many Employees Work at Manav Rakshak Hospitals?
Unlock and access historical data on people associated with Manav Rakshak Hospitals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Manav Rakshak Hospitals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Manav Rakshak Hospitals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED_354462.webp){kind=small}
